Azilsartan

Archie, sand jotham ester (English: Azilsartan medoxomil) is a (INN) is developed in the treatment of hypertension of the angiotensin II receptor antagonist drugs, used in the treatment of hypertension, is currently the only at the end of the clinical angiotensin II receptor antagonist drugs statins (sand).
On April 28, 2010, Japanese Takeda pharmaceuticals (Takeda) research and development of the drug has completed phase iii trial, in 2011 the FDA approval, the drug as an angiotensin II receptor antagonist, can be used alone or in combination with other blood pressure medicines, is seen as the next generation of candesartan ester products.
Azilsartan medoxomil for the kind of white powder, its Chinese name:
Archie, sand temple Chinese alias: 2 - ethoxy - 1 - [[2 '- (4, 5 - dihydro - 5 - oxygen 4-trichlorobenzene oxadiazoles generation - 1-3 - base) biphenyl methyl - 4 - base]] benzene and imidazole - 7 - carboxylic acid;Clindamycin.2 ethoxy - 3 - (2 '- (5 - oxygen generation - 2, 5 - dihydro 1, 4-trichlorobenzene oxadiazoles - 3 - base) biphenyl - 4 - base) methyl) - 3 h - benzo [D] imidazole - 4 - formic acid;2 - ethoxy - 1 - [[2 '- (4, 5 - dihydro - 5-4-trichlorobenzene oxadiazoles oxygen generation - 1-3 - base) biphenyl methyl - 4 - base]] benzene and imidazole - 7 - carboxylic acid;
English name: azilsartan
English alias: Azilsartan;UNII - F9NUX55P23;2 ethoxy - 3 - [(4 - [2 - (5 - oxo - 2 h - 1, 4-trichlorobenzene oxadiazol - 3 - yl) phenyl] phenyl] methyl] benzimidazole - 4 - carboxylic acid;
CAS no. : 147403-03-0
Molecular formula: C25H20N4O5
Molecular weight: 456.45000

Declaration: the product patent protection for the product catalog are used by laboratory analysis or research and development purposes, and may not be sold to any national and regional patent protection, risk and liability if the resulting patent infringement, will be the buyer.